Triamcinolone Acetonide Ointment 0.1% (Aristocort) by Perrigo is used to reduce the actions of chemicals in the body that cause inflammation, redness, and swelling. Triamcinolone topical is used to treat the inflammation caused by several conditions, such as allergic reactions, eczema, and psoriasis. The dental paste form of triamcinolone is used to treat mouth ulcers.
Use this medication only on the skin. Do not use it on the face, groin, or underarms unless directed to do so by your doctor.
Wash and dry your hands. Before applying the medication, clean and dry the affected area. Apply a thin film of the medication to the affected area and gently rub in, usually 2 to 4 times daily or as directed by your doctor. Do not cover, bandage or wrap the area unless directed to do so by your doctor. If used in the diaper area on an infant, do not use tight-fitting diapers or plastic pants.
After applying the medication, wash your hands unless you are using this medication to treat the hands. When applying this medication near the eyes, avoid getting it in the eyes as this may worsen or cause glaucoma. Also, avoid getting this medication in the nose or mouth. If you get the medication in your eyes, nose, or mouth, rinse with plenty of water.
Brand: Perrigo
Size: 454 grams (1 Pound)
NDC: 45802-0055-05
UPC: 345802055057
Buy Perrigo Triamcinolone Acetonide Ointment 0.1% Jar, 1 Pound online at Mountainside Medical Equipment.
- FDA-approved indication: Intended to support relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, per FDA-approved prescribing information for triamcinolone acetonide topical formulations (ref: DailyMed NDC 45802-0055-05)
- Clinical applications: Commonly applied in dermatology, primary care, wound care, and medspa settings to support management of atopic dermatitis (eczema), plaque psoriasis, contact dermatitis, seborrheic dermatitis, and allergic inflammatory skin conditions in patients under licensed clinical care
- Formulation selection: The ointment vehicle is the clinically preferred format for dry, thickened, lichenified, or scaly lesions; the occlusive petrolatum base enhances corticosteroid penetration into the stratum corneum — cream formulations are more appropriate for moist, acutely inflamed, or intertriginous presentations
- Application protocol: Apply a thin film to the clean, dry affected skin area 2 to 4 times daily or as directed by the prescribing clinician; do not bandage, wrap, or occlude the treated area unless specifically directed by the clinician
- Anatomical restrictions: Not intended for application to the face, groin, or underarm areas unless specifically directed by a licensed prescriber; these regions have thinner skin and higher percutaneous absorption rates, increasing risk of local and systemic adverse effects
- Paediatric use: When applied in the diaper area of infants, tight-fitting diapers or occlusive plastic pants must not be used — occlusion significantly increases systemic absorption of the corticosteroid in this population
- Professional oversight required: For use by or under the direction of a licensed healthcare professional; clinicians must consult the full FDA-approved prescribing information and package insert before clinical application
This product is intended for use by qualified healthcare professionals or under the guidance of a licensed medical provider. It is not a substitute for professional medical advice, diagnosis, or treatment.
- Prescription-only product: Triamcinolone acetonide ointment USP 0.1% is not approved for over-the-counter use in the United States; it requires a valid prescription and must be used under the direction of a licensed prescriber
- Restricted anatomical sites: Do not apply to the face, groin, or underarm areas unless specifically directed by a licensed clinician; application to thin or sensitive skin carries a significantly elevated risk of skin atrophy, telangiectasia, and striae
- Ocular exposure risk: Avoid contact with the eyes; inadvertent ophthalmic exposure may worsen pre-existing glaucoma or precipitate new-onset glaucoma or cataracts with prolonged near-eye application; if eye contact occurs, rinse immediately and thoroughly with water
- Systemic absorption and HPA axis suppression: Prolonged use, large surface area application, or use under occlusive dressings may result in HPA axis suppression, Cushing's syndrome features, or hyperglycaemia — risks are elevated in paediatric patients, patients with compromised skin barriers, and those treated with occlusion
- Paediatric occlusion warning: In infants and young children, do not use tight-fitting diapers or occlusive plastic pants over treated skin areas; occlusion dramatically increases percutaneous absorption and systemic exposure to the corticosteroid
- Infection contraindication: Do not apply to untreated bacterial, fungal, or viral skin infections; topical corticosteroids may mask signs of infection and suppress local immune response, potentially worsening an underlying infectious process
- Full prescribing information: This safety summary does not replace the complete FDA-approved prescribing information; all prescribing clinicians and dispensing professionals must consult the full label, available via DailyMed (NDC: 45802-0055-05), before clinical use
This product is intended for use by qualified healthcare professionals or under the guidance of a licensed medical provider. It is not a substitute for professional medical advice, diagnosis, or treatment.
Professional Use Only: Triamcinolone Acetonide Ointment USP 0.1% is intended for purchase and use by licensed healthcare professionals only. This product requires a valid prescription and is not approved for over-the-counter sale or use without the supervision of a licensed prescriber.
Clinical Information Disclaimer: The clinical and pharmaceutical information provided on this page is intended for reference purposes by qualified healthcare professionals only. It does not constitute medical advice, a clinical recommendation, or a substitute for the full FDA-approved prescribing information. All prescribing clinicians and dispensing professionals must consult the complete package insert and FDA-approved label before clinical use. The full prescribing information for this product is accessible via the US National Library of Medicine DailyMed database (NDC: 45802-0055-05).
Regulatory Reference: All indications referenced on this page reflect FDA-approved prescribing information for triamcinolone acetonide topical formulations as documented by the National Library of Medicine DailyMed database. Mountainside Medical Equipment does not make independent clinical efficacy or safety claims beyond those supported by the FDA-approved label for this product.
Manufacturer Information: This product is manufactured by Perrigo / Padagis. Mountainside Medical Equipment is a wholesale distributor and does not manufacture, reformulate, or repackage this product. Manufacturer specifications, quality standards, and regulatory standing are as represented by the manufacturer and identified by NDC 45802-0055-05. No additional manufacturer quality, country of origin, or regulatory claims beyond those present in the provided product data are made or implied.
For clinical guidance, consult a licensed pharmacist or physician. For ordering, licensing, and account enquiries, contact Mountainside Medical Equipment at +1 (888) 687-4334 or sales@mountainside-medical.com.